{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "11588693",
  "DateCompleted": {
    "Year": "2002",
    "Month": "01",
    "Day": "09"
  },
  "DateRevised": {
    "Year": "2020",
    "Month": "04",
    "Day": "03"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2001",
        "Month": "10",
        "Day": "04"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "1058-4838",
      "JournalIssue": {
        "Volume": "33",
        "Issue": "9",
        "PubDate": {
          "Year": "2001",
          "Month": "Nov",
          "Day": "01"
        }
      },
      "Title": "Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",
      "ISOAbbreviation": "Clin Infect Dis"
    },
    "ArticleTitle": "Variant effect of first- and second-generation antihistamines as clues to their mechanism of action on the sneeze reflex in the common cold.",
    "Pagination": {
      "StartPage": "1483",
      "EndPage": "1488",
      "MedlinePgn": "1483-8"
    },
    "Abstract": {
      "AbstractText": [
        "Treatment with first-generation antihistamines reduces sneezing, rhinorrhea, nasal mucus weight, and, in some instances, cough in subjects with experimental or natural colds; however, treatment with second-generation antihistamines has not been effective for these complaints in trials in subjects with natural colds. This article reports the negative results of a clinical trial with loratadine, a second-generation antihistamine, in adults in the rhinovirus challenge model. This finding in the highly controlled setting of the challenge model confirms the earlier negative studies with second-generation antihistamines in natural colds. First-generation antihistamines block both histaminic and muscarinic receptors as well as passing the blood-brain barrier. Second-generation antihistamines mainly block histaminic receptors and do not pass the blood-brain barrier. The effectiveness of first-generation antihistamines in blocking sneezing in colds may be due primarily to neuropharmacological manipulation of histaminic and muscarinic receptors in the medulla."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Aachen Medical School, Aachen, Germany."
          }
        ],
        "LastName": "Muether",
        "ForeName": "P S",
        "Initials": "PS"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Gwaltney",
        "ForeName": "J M",
        "Initials": "JM",
        "Suffix": "Jr"
      }
    ],
    "PublicationTypeList": [
      "Clinical Trial",
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Clin Infect Dis",
    "NlmUniqueID": "9203213",
    "ISSNLinking": "1058-4838"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Histamine H1 Antagonists"
    },
    {
      "RegistryNumber": "126547-89-5",
      "NameOfSubstance": "Intercellular Adhesion Molecule-1"
    },
    {
      "RegistryNumber": "7AJO3BO7QN",
      "NameOfSubstance": "Loratadine"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [
        "drug therapy",
        "metabolism",
        "physiopathology",
        "virology"
      ],
      "DescriptorName": "Common Cold"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Histamine H1 Antagonists"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Intercellular Adhesion Molecule-1"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Loratadine"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Mucus"
    },
    {
      "QualifierName": [
        "drug effects",
        "metabolism"
      ],
      "DescriptorName": "Rhinovirus"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Sneezing"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Treatment Outcome"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Viral Load"
    }
  ]
}